Published in Hemodial Int on May 12, 2009
Dialysis dose and intradialytic hypotension: results from the HEMO study. Am J Nephrol (2013) 0.91
Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation. Am J Nephrol (2012) 0.80
Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline. Am J Kidney Dis (2015) 0.76
Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol (2009) 3.19
Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol (2010) 2.69
Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol (2012) 2.44
A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis (2008) 2.38
Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol (2011) 2.08
Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant (2009) 2.02
Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol (2007) 1.92
A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant (2006) 1.80
Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate. Clin J Am Soc Nephrol (2006) 1.78
Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol (2009) 1.78
Peritoneal dialysis is not associated with myocardial stunning. Perit Dial Int (2010) 1.52
Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis. Am J Kidney Dis (2006) 1.49
Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant (2005) 1.48
Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin. Nephrol Dial Transplant (2005) 1.43
The acute cardiac effects of dialysis. Semin Dial (2007) 1.17
Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5. Nephron Clin Pract (2007) 1.17
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res (2009) 1.15
Recurrent circulatory stress: the dark side of dialysis. Semin Dial (2010) 1.12
Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation (2009) 1.12
Calcium exposure and removal in chronic hemodialysis patients. J Ren Nutr (2006) 1.12
Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant (2005) 1.11
Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol (2011) 1.09
Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant (2008) 1.09
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis (2012) 1.08
Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol (2009) 1.08
Dialysis-induced myocardial stunning: the other side of the cardiorenal syndrome. Rev Cardiovasc Med (2011) 1.07
Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant (2011) 1.05
Risk profile in chronic kidney disease stage 3: older versus younger patients. Nephron Clin Pract (2011) 1.02
Automated peritoneal dialysis has significant effects on systemic hemodynamics. Perit Dial Int (2006) 1.02
Are there neurological consequences of recurrent intradialytic hypotension? Semin Dial (2012) 1.02
Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One (2012) 1.01
Online conductivity monitoring: validation and usefulness in a clinical trial of reduced dialysate conductivity. ASAIO J (2005) 1.01
Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant (2011) 1.00
Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias. Ren Fail (2008) 1.00
Development of a formula for estimation of sodium intake from spot urine in people with chronic kidney disease. Nephron Clin Pract (2014) 1.00
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care. BMC Fam Pract (2013) 1.00
Defining the cause of death in hospitalised patients with acute kidney injury. PLoS One (2012) 0.99
Venography at insertion of tunnelled internal jugular vein dialysis catheters reveals significant occult stenosis. Nephrol Dial Transplant (2004) 0.99
Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability. Blood Purif (2011) 0.97
Assessment of haemodialysis adequacy by ionic dialysance: intra-patient variability of delivered treatment. Nephrol Dial Transplant (2003) 0.95
Buttonhole needling of ateriovenous fistulae: a randomized controlled trial. ASAIO J (2010) 0.95
Tissue-advanced glycation end product concentration in dialysis patients. Clin J Am Soc Nephrol (2009) 0.95
Benefits of regular walking exercise in advanced pre-dialysis chronic kidney disease. Nephrol Dial Transplant (2011) 0.95
Hemodialysis-associated cardiomyopathy: a newly defined disease entity. Semin Dial (2014) 0.94
Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int (2003) 0.94
Vascular calcification is associated with impaired microcirculatory function in chronic haemodialysis patients. Nephron Clin Pract (2008) 0.93
A non-invasive, on-line deuterium dilution technique for the measurement of total body water in haemodialysis patients. Nephrol Dial Transplant (2008) 0.92
Analysis of factors associated with variability in haemodialysis adequacy. Nephrol Dial Transplant (2004) 0.90
Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.88
Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO J (2006) 0.88
Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS One (2013) 0.86
The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant (2006) 0.84
Use of albumin dialysis in the treatment of hepatic and renal dysfunction due to paracetamol intoxication. Nephrol Dial Transplant (2002) 0.84
The reimbursement and cost of acute kidney injury: a UK hospital perspective. Nephron Clin Pract (2014) 0.83
Comparison of progressive conductivity reduction with diacontrol and standard dialysis. ASAIO J (2007) 0.82
Determinants of survival in patients receiving dialysis in Libya. Hemodial Int (2012) 0.82
Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study. Nephrol Dial Transplant (2010) 0.81
N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning. Nephron Clin Pract (2013) 0.81
The assessment of baroreflex sensitivity in patients with chronic kidney disease: implications for vasomotor instability. Curr Opin Nephrol Hypertens (2005) 0.81
Preventing catheter related infections in haemodialysis patients. Curr Opin Nephrol Hypertens (2006) 0.81
Circulating endotoxaemia and frequent haemodialysis schedules. Nephron Clin Pract (2014) 0.81
Higher arteriovenous fistulae blood flows are associated with a lower level of dialysis-induced cardiac injury. Hemodial Int (2009) 0.81
The vicious cycle of dialysis-induced cardiac injury--are dynamic changes in diastolic function involved? Am J Kidney Dis (2013) 0.81
Online measurement of haemoglobin concentration. Nephrol Dial Transplant (2005) 0.80
Is it practical to screen dialysis patients for vascular calcification? Nephrol Dial Transplant (2005) 0.80
The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.80
Incident isolated 1,25(OH)(2)D(3) deficiency is more common than 25(OH)D deficiency in CKD. J Nephrol (2012) 0.80
Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3. Nephron Clin Pract (2013) 0.80
Provision and quality of dialysis services in Libya. Hemodial Int (2011) 0.79
How should dialysis fluid be individualized for the chronic hemodialysis patient? Temperature. Semin Dial (2008) 0.79
Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. BMC Nephrol (2012) 0.79
Natural history of skeletal muscle mass changes in chronic kidney disease stage 4 and 5 patients: an observational study. PLoS One (2013) 0.79
Tissue advanced glycation end product deposition after kidney transplantation. Nephron Clin Pract (2013) 0.78
Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance? PLoS One (2012) 0.78
Vascular access in patients receiving hemodialysis in Libya. J Vasc Access (2013) 0.78
The authors reply. Kidney Int (2013) 0.78
Central venous oxygen saturation: a potential new marker for circulatory stress in haemodialysis patients? Nephron Clin Pract (2014) 0.78
How is the heart best protected in chronic dialysis patients?: Protecting the heart in dialysis patients--intra-dialytic issues. Semin Dial (2014) 0.78
The pathophysiology of the chronic cardiorenal syndrome: a magnetic resonance imaging study. Eur Radiol (2015) 0.78
The effects of acute kidney injury on long-term renal function and proteinuria in a general hospitalised population. Nephron Clin Pract (2014) 0.77
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression. Eur J Appl Physiol (2013) 0.77
Differential microvasculature dysfunction in living kidney donor transplant recipients: nondialyzed versus dialyzed chronic kidney disease patients. J Vasc Res (2009) 0.77
MRI for the assessment of organ perfusion in patients with chronic kidney disease. Curr Opin Nephrol Hypertens (2012) 0.76